# FDA Inspection 1040461 - SOLCO BIOMEDICAL CORPORATION - January 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/solco-biomedical-corporation/3f6a57dc-7666-49f7-9644-1ca769b23a39
Source feed: FDA_Inspections

> FDA Inspection 1040461 for SOLCO BIOMEDICAL CORPORATION on January 25, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040461
- Company Name: SOLCO BIOMEDICAL CORPORATION
- Inspection Date: 2018-01-25
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1107785 - 2019-10-03](https://www.keypedia.com/records/fda_inspections/solco-biomedical-corporation/47ab19bb-7db4-467b-989a-3abe9e8ccd8b)
- [FDA Inspection 1107785 - 2019-10-03](https://www.keypedia.com/records/fda_inspections/solco-biomedical-corporation/398d4af7-1387-4b05-a7ee-6f16d2810169)

Company: https://www.keypedia.com/companies/solco-biomedical-corporation/c5536e9b-0b65-4050-8582-c3959600a38e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d